Updates on BTK Inhibitors and Multiple Sclerosis Trials - Part 2

30 Jul 2026 · 20 min

Episode Updates on BTK Inhibitors and Multiple Sclerosis Trials - Part 2

0:00 20:27

In part two of this series, Dr. Shuvro Roy talks with Drs. Jiwon Oh and Amit Bar-Or about the latest developments in BTK inhibitors for MS, including safety signals, trial results, and future directions.

For more information, please read about the abstract that was presented at the 2026 AAN Annual Meeting.

Read more about the Fenebrutinib Trial.

Disclosures can be found at Neurology.org.

Links in the notes 3

https://www.aan.com/msa/Public/Events/AbstractDetails/65031
https://www.roche.com/media/releases/med-cor-2026-02-07
https://www.neurology.org/

The episode on the publisher’s site (opens in a new tab)

Shows are listed from Apple Podcasts' charts and directory, and Podcast Index where it is used. Every show and episode belongs to its publisher and plays from the publisher's own feed; this site hosts none of them. Explicit shows are for adult profiles only, and children’s profiles hear only children’s shows. More about this list.